Impact of Pharmaceutical Promotion on Doctors' Prescribing Decisions
Author Information
Author(s): Vancelik Serhat, Beyhun Nazim E, Acemoglu Hamit, Calikoglu Oksan
Primary Institution: Ataturk University, School of Medicine, Erzurum, Turkey
Hypothesis
The study aimed to determine the self-reported impact of pharmaceutical promotion on the decision-making process of prescription of GPs in Eastern Turkey.
Conclusion
The study found that the majority of GPs reported that their prescribing decisions were significantly influenced by commercial information provided by pharmaceutical sales representatives.
Supporting Evidence
- 73.7% of GPs used drug guides from pharmaceutical companies as their primary resource for prescribing.
- 61.2% of GPs reported that their prescribing decisions were always affected by sales representatives' activities.
- The study had a high participation rate of 96.8% among GPs in the region.
Takeaway
Doctors in Eastern Turkey often rely on information from drug companies when deciding what medicines to prescribe, which can affect their choices.
Methodology
A cross-sectional survey was conducted using a self-administered structured questionnaire among 152 general practitioners.
Potential Biases
Self-reporting may introduce bias as GPs might underestimate the influence of pharmaceutical representatives.
Limitations
The study relied on self-reported data, which may lead to underestimation of the influence of pharmaceutical promotion.
Participant Demographics
53.3% male, 65.8% working at primary health care centers, mean years of practice 6.3.
Statistical Information
P-Value
0.019
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website